Predictors of long-term drug survival for infliximab in psoriasis

被引：0
|
作者：
Magis, Q. [1 ]
Jullien, D. [2 ]
Gaudy, C. [1 ]
Baumstark, K. [3 ]
Viguier, M. [4 ]
Bachelez, H. [5 ]
Guibal, F. [6 ]
Delaporte, E. [7 ]
Karimova, E. [7 ]
Montaudie, H. [8 ]
Boye, T. [9 ]
Aubin, F. [10 ]
Beylot-Barry, M. [11 ]
Richard, M. -A. [1 ]
机构：
[1] Hop La Timone, Dermatol, Marseille, France
[2] Hop Edouard Herriot, Lyon, France
[3] Aix Marseille Univ, Clin Res, Marseille, France
[4] Hop La Sorbonne, Dermatol, Paris, France
[5] Hop St Louis, Paris, France
[6] Hop St Louis, Dermatol, Paris, France
[7] Reg Univ Hosp, Lille, France
[8] Hop LArchet, Nice, France
[9] Hop Instruct Armees St Anne, Dermatol, Toulon, France
[10] Hop Jean Minjoz, Dermatoloie, Besancon, France
[11] Hop St Andre, Dermatol, Bordeaux, France
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2016年 / 30卷
关键词：
infliximab; long-term drug survival; predictors of long term survival;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P192
引用
收藏
页码：96 / 97
页数：2
相关论文
共 50 条
  • [1] Predictors of long-term drug survival for infliximab in psoriasis
    Magis, Q.
    Jullien, D.
    Gaudy-Marqueste, C.
    Baumstark, K.
    Viguier, M.
    Bachelez, H.
    Guibal, F.
    Delaporte, E.
    Karimova, E.
    Montaudie, H.
    Boye, T.
    Aubin, F.
    Beylot-Barry, M.
    Richard, M. -A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (01) : 96 - 101
  • [2] Long-term study of infliximab for psoriasis in daily practice: drug survival depends on combined treatment, obesity and infusion reactions
    Spertino, J.
    Lopez-Ferrer, A.
    Vilarrasa, E.
    Puig, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (11) : 1514 - 1521
  • [3] Complementary data for long-term infliximab use in psoriasis
    Mansouri, Bobbak
    Menter, Alan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (03) : 591 - 591
  • [4] Factors influencing the efficacy of the long-term treatment of psoriasis with infliximab
    Gniadecki, R.
    Aagard, S. M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S20 - S20
  • [5] Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate
    Warren, R. B.
    Brown, B. C.
    Carmichael, A. J.
    Griffiths, C. E. M.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (03) : 416 - 416
  • [6] Infliximab combined with methotrexate as long-term treatment for erythrodermic psoriasis
    Heikkilä, H
    Ranki, A
    Cajanus, S
    Karvonen, SL
    ARCHIVES OF DERMATOLOGY, 2005, 141 (12) : 1607 - 1610
  • [7] Long-term, real-world efficacy of infliximab for psoriasis
    Mercieca, L.
    Warren, R. B.
    Griffiths, C. E. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E301 - E301
  • [8] Drug survival for adalimumab in a long-term daily practice cohort of patients with psoriasis
    Julia Manresa, Marc
    Arrue Michelena, Itziar
    Almeida Llamas, Victoria
    Carnero Gonzalez, Lucia
    de Lagran Alvarez de Arcaya, Zurine Martinez
    Ruiz Carrillo, Gorka
    Piqueres Zubiaurre, Tatiana
    Urtaran Ibarzabal, Amaia
    Heras Gonzalez, Sonia
    Gonzalez Perez, Ricardo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB207 - AB207
  • [9] Long-term safety and drug survival of acitretin in psoriasis: a retrospective observational study
    Chularojanamontri, Leena
    Silpa-archa, Narumol
    Wongpraparut, Chanisada
    Limphoka, Pichaya
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2019, 58 (05) : 593 - 599
  • [10] Drug Survival and Long-Term Dose Comparison of Etanercept and Infliximab in Rheumatoid Arthritis Patients
    Hanna, Brian D.
    Shah, Alpesh
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S477 - S477
12345